Merck (MRK) on Friday reported a loss for the fourth-quarter that widened from last year, reflecting a $2.6 billion provisional charge related to the U.S. tax legislation. Worldwide sales increased 3 percent. Adjusted earnings per share topped analysts' expectations, while quarterly sales missed their estimates. It expects adjusted earnings per share for 2018 to be in line with analysts' view.
from RTT - Earnings http://ift.tt/2nxEeWU
via IFTTT
No comments:
Post a Comment